Variant report
Variant | esv3340441 |
---|---|
Chromosome Location | chr9:16906902-16908975 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10756837 | chr9:16906904-16906905 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189432824 | chr9:16906917-16906918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540495454 | chr9:16906943-16906944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182258162 | chr9:16906944-16906945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573854995 | chr9:16906993-16906994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184375102 | chr9:16907017-16907018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200502303 | chr9:16907035-16907036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369148409 | chr9:16907036-16907037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144498137 | chr9:16907041-16907042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533505077 | chr9:16907064-16907065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113719473 | chr9:16907091-16907092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551466807 | chr9:16907119-16907120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111418452 | chr9:16907124-16907125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371286187 | chr9:16907135-16907136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575479876 | chr9:16907139-16907140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75046824 | chr9:16907141-16907142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370710426 | chr9:16907145-16907146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10810663 | chr9:16907149-16907150 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs115029795 | chr9:16907181-16907182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79271589 | chr9:16907232-16907233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs57198485 | chr9:16907239-16907240 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs539556063 | chr9:16907243-16907244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561508133 | chr9:16907245-16907246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557588438 | chr9:16907258-16907259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112367492 | chr9:16907313-16907314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181163239 | chr9:16907347-16907348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573506445 | chr9:16907358-16907359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147853695 | chr9:16907385-16907386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562429706 | chr9:16907412-16907413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544089162 | chr9:16907415-16907416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141304021 | chr9:16907425-16907426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185519896 | chr9:16907432-16907433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556748459 | chr9:16907442-16907443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578016209 | chr9:16907443-16907444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551462030 | chr9:16907469-16907470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545459006 | chr9:16907488-16907489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560401198 | chr9:16907509-16907510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527647452 | chr9:16907529-16907530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543049775 | chr9:16907546-16907547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113780397 | chr9:16907584-16907585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9697099 | chr9:16907621-16907622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190321642 | chr9:16907623-16907624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74879983 | chr9:16907645-16907646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181552334 | chr9:16907646-16907647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74367130 | chr9:16907649-16907650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111637410 | chr9:16907650-16907651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567812855 | chr9:16907665-16907666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186016051 | chr9:16907671-16907672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76718132 | chr9:16907675-16907676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183993950 | chr9:16907676-16907677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:16902000-16914800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr9:16908200-16908600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |